prospectives on neuro-oncology field. need advice
Good evening
I'm considering neuro-oncology as a fellowship and I do have a couple of questions about it
- I heard from a neurooncologist in my institution that the field is currently unstable as no treatments are emerging and most of the therapies will be challenged in the future by insurance companies because they don't add much to neuro-oncology patients. So my question is, what is the future of this field and is it going to be fade away because it is solely a diagnostic field?
-...
Read more (Source: Student Doctor Network)
Source: Student Doctor Network - June 8, 2021 Category: Universities & Medical Training Authors: Temodar Tags: Neurology Source Type: forums
Concurrent temodar with hypofractionated GBM treatment?
Thinking of original Roa dose of 4005 cGy in 15 fx in an elderly patient with a good PS, mainly out of social convenience. Med onc wants to give Temodar. Anyone doing concurrent with hypofractionated. My impression is, it's probably fine. (Source: Student Doctor Network)
Source: Student Doctor Network - February 24, 2021 Category: Universities & Medical Training Authors: Mandelin Rain Tags: Radiation Oncology Source Type: forums
Can/should you add Tmz to short course RT for GBM in the elderly? Yes.
In elderly patients with glioblastoma, the addition of temozolomide to short-course radiotherapy resulted in longer survival than short-course radiotherapy alone.
An interesting discussion: not adding Tmz for uMGMT older patients based on this data (a point they seem intentionally not to make in the abstract). I'm not sure what the reticence is to make Tmz treatment recommendations based on MGMT status. Just the general...
Can/should you add Tmz to short course RT for GBM in the elderly? Yes. (Source: Student Doctor Network)
Source: Student Doctor Network - March 27, 2017 Category: Universities & Medical Training Authors: scarbrtj Source Type: forums
